Metastatic pancreatic cancer responds well to treatment with… | HappeningNow.news

Health · 5 views

Metastatic pancreatic cancer responds well to treatment with combination of daraxonrasib and chemotherapy

Source Summary Published 13m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 5 Community interest
Brief read Under 1 min brief 32 words

Summary

Daraxonrasib combined with chemotherapy caused substantial tumor shrinkage in patients with pancreatic cancer that had spread to other parts of the body, according to new results from a Phase I/II clinical trial.

Read original at Medical Xpress

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page